Detalhe da pesquisa
1.
Randomized phase 2 trial of tremelimumab and durvalumab in combination versus sequentially in recurrent platinum-resistant ovarian cancer.
Cancer
; 130(7): 1061-1071, 2024 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38009662
2.
Determination of quality of life-related health utilities for surgical complications in ovarian cancer.
Gynecol Oncol
; 185: 101-107, 2024 Feb 19.
Artigo
Inglês
| MEDLINE | ID: mdl-38377761
3.
Experiences of patients with peritoneal carcinomatosis-related complex care needs and their caregivers.
Gynecol Oncol
; 181: 68-75, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38141533
4.
Efficacy, safety, and feasibility of Apixaban for postoperative venous thromboembolism prophylaxis following open gynecologic cancer surgery at a comprehensive cancer center.
Gynecol Oncol
; 2024 Feb 16.
Artigo
Inglês
| MEDLINE | ID: mdl-38368180
5.
Longitudinal perioperative patient-reported outcomes in open compared with minimally invasive hysterectomy.
Am J Obstet Gynecol
; 230(2): 241.e1-241.e18, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-37827271
6.
Medicaid Expansion and Postoperative Mortality in Women with Gynecologic Cancer: A Difference-in-Difference Analysis.
Ann Surg Oncol
; 30(3): 1508-1519, 2023 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-36310311
7.
Rate of venous thromboembolism on an enhanced recovery program after gynecologic surgery.
Am J Obstet Gynecol
; 229(2): 140.e1-140.e7, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37150284
8.
Patient-reported symptoms at discharge and risk of complications after gynecologic surgery.
Int J Gynecol Cancer
; 33(2): 271-277, 2023 02 06.
Artigo
Inglês
| MEDLINE | ID: mdl-36600503
9.
Secondary validation of an ovarian cancer-specific comorbidity index in a US population.
Int J Gynecol Cancer
; 33(5): 749-754, 2023 05 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36863760
10.
Evaluation of a tiered opioid prescription algorithm in an ERAS pathway: exploring opportunities for further refinement.
Int J Gynecol Cancer
; 2023 Dec 20.
Artigo
Inglês
| MEDLINE | ID: mdl-38123191
11.
Frailty repels the knife: The impact of frailty index on surgical intervention and outcomes.
Gynecol Oncol
; 166(1): 50-56, 2022 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35599168
12.
Medicaid expansion and 2-year survival in women with gynecologic cancer: a difference-in-difference analysis.
Am J Obstet Gynecol
; 227(3): 482.e1-482.e15, 2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35500609
13.
Temporal trends of healthcare system use between symptomatic presentation and ovarian cancer diagnosis in the United States.
Int J Gynecol Cancer
; 32(7): 899-905, 2022 07 04.
Artigo
Inglês
| MEDLINE | ID: mdl-35331992
14.
Patient outcomes and adherence to an enhanced recovery pathway for open gynecologic surgery: a 6-year single-center experience.
Int J Gynecol Cancer
; 2022 Oct 06.
Artigo
Inglês
| MEDLINE | ID: mdl-36202425
15.
Employment disruption among women with gynecologic cancers.
Int J Gynecol Cancer
; 32(1): 69-78, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34785522
16.
Impact of timing of urinary catheter removal on voiding dysfunction after radical hysterectomy for early cervical cancer.
Int J Gynecol Cancer
; 2022 Jul 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35803608
17.
Association between time to diagnosis, time to treatment, and ovarian cancer survival in the United States.
Int J Gynecol Cancer
; 32(9): 1153-1163, 2022 09 06.
Artigo
Inglês
| MEDLINE | ID: mdl-36166208
18.
Factors impacting the time to ovarian cancer diagnosis based on classic symptom presentation in the United States.
Cancer
; 127(22): 4151-4160, 2021 Nov 15.
Artigo
Inglês
| MEDLINE | ID: mdl-34347287
19.
Hypomagnesemia and survival in patients with head and neck cancers who received primary concurrent chemoradiation.
Cancer
; 127(4): 528-534, 2021 02 15.
Artigo
Inglês
| MEDLINE | ID: mdl-33085092
20.
Timing of surgery in patients with partial response or stable disease after neoadjuvant chemotherapy for advanced ovarian cancer.
Gynecol Oncol
; 161(3): 660-667, 2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33867146